FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, USA. USA, May 1, 2018. REUTERS / Stephen Lam (Reuters) – Gilead Sciences Inc’s (GILD.O) Antiviral remdesivir could be priced up to $ 5,080 per course based on the benefits shown in COVID-19 …
Read More »US group raises price recommendation to rebrand Gilead at COVID-19
